These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37510119)
21. Gender-specific nomogram models to predict the prognosis of male and female lung adenocarcinoma patients: a population-based analysis. Wen H; Lin X; Sun D Ann Transl Med; 2021 Nov; 9(22):1654. PubMed ID: 34988163 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study. Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614 [TBL] [Abstract][Full Text] [Related]
23. Development and validation of a CT-based nomogram to predict spread through air space (STAS) in peripheral stage IA lung adenocarcinoma. Chen Y; Jiang C; Kang W; Gong J; Luo D; You S; Cheng Z; Luo Y; Wu K Jpn J Radiol; 2022 Jun; 40(6):586-594. PubMed ID: 35079955 [TBL] [Abstract][Full Text] [Related]
24. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer. Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629 [TBL] [Abstract][Full Text] [Related]
25. Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma. Zhao L; Bai G; Ji Y; Peng Y; Zang R; Gao S Front Oncol; 2021; 11():749643. PubMed ID: 35096566 [TBL] [Abstract][Full Text] [Related]
26. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule. Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575 [TBL] [Abstract][Full Text] [Related]
27. Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery. Guo Z; Guo H; Tian Y; Zhang Z; Zhao Q Front Oncol; 2022; 12():908229. PubMed ID: 35756688 [TBL] [Abstract][Full Text] [Related]
28. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma. Jeon HW; Kim YD; Sim SB; Moon MH Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities. Xi J; Yin J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q Front Oncol; 2021; 11():616149. PubMed ID: 33912445 [TBL] [Abstract][Full Text] [Related]
30. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma. Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907 [TBL] [Abstract][Full Text] [Related]
31. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy. Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907 [TBL] [Abstract][Full Text] [Related]
32. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
33. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma. Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014 [TBL] [Abstract][Full Text] [Related]
34. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE. Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X Front Oncol; 2021; 11():742630. PubMed ID: 34745962 [TBL] [Abstract][Full Text] [Related]
35. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
36. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer. Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614 [TBL] [Abstract][Full Text] [Related]
37. Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score. Zhao L; Sun J; Wang K; Tai S; Hua R; Yu Y; Fan Y; Huang J Cancer Manag Res; 2021; 13():6473-6487. PubMed ID: 34429654 [TBL] [Abstract][Full Text] [Related]
38. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer. Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444 [TBL] [Abstract][Full Text] [Related]
39. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery. Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559 [TBL] [Abstract][Full Text] [Related]
40. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study. Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]